Event Details We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need. IR Sub Menu Investors & Media Corporate Profile Press Releases Events & Presentations Publications H.C. Wainwright Cell Therapy Virtual Conference Feb 28, 2023 at 11:00 AM EST Register for the Webcast
H.C. Wainwright Cell Therapy Virtual Conference Feb 28, 2023 at 11:00 AM EST Register for the Webcast